Professor Xu Yi from Yinfeng Cryomedicine Expert Committee Elected as Board Governor of International Society of Cryobiology
Release time:
2025-12-19
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.

Newly Elected Board Governors (2026–2028)
Professor Xu Yi studied under the guidance of Mr. Hua Zezhao, a pioneering figure in China’s cryobiological medical engineering. He currently serves as the third Director of the Institute of Biothermal Science and Technology at the University of Shanghai for Science and Technology and holds the position of Deputy Director of the Small Refrigeration and Cryobiological Medicine Committee of the Chinese Association of Refrigeration. In recent years, Professor Xu has focused on critical national strategic tasks such as safeguarding biological resources and advancing precision cell therapy. He has led several national-level projects, including major national science and technology programs and general projects of the National Natural Science Foundation. He authored China’s first standard for the cryopreservation of pathogenic microorganisms, successfully achieved the large-scale cryopreservation of clinical-grade liver organoids for the first time in China, and pioneered an innovative method for loading cryoprotectants driven by evaporation, a groundbreaking approach internationally. Professor Xu Yi’s research achievements have garnered attention from peers both domestically and abroad, establishing him as a leading figure in China’s cryobiological medical engineering field.
Shandong Yinfeng Institute of Life Sciences is a non-profit research institution approved by the Shandong Provincial Department of Civil Affairs. It is dedicated to the research and transformation of technologies and products in fields such as gene technology, cell technology, cryomedicine, and regenerative medicine. The institute comprises several research centers, including the Beijing R&D Center, Cell Medicine Research Center, Regenerative Medicine Research Center, Cryomedicine Research Center, Cryogenic Engineering Research Center, and Gene Technology Research Center. Among them, the Cryomedicine Research Center focuses on the development of cryoprotectants, cryomedical devices and equipment, as well as research on cryopreservation and rewarming technologies for human cells, tissues, and organs, along with the cryopreservation and rewarming of complete organisms. Over the years, Shandong Yinfeng Institute of Life Sciences has collaborated with the University of Shanghai for Science and Technology in industry-academia-research partnerships, establishing an internship base at the School of Medical Instruments and Food Engineering. Together, they have conducted research on deep cryopreservation of tissues and organs, the construction of biological tissue engineering materials, and standardization projects, achieving numerous research outcomes.
In the future, Shandong Yinfeng Institute of Life Sciences will continue to gather leading domestic and international institutions and authoritative experts, striving to build a world-class research and innovation base for life sciences and cryobiological medicine, contributing Yinfeng’s strength to the advancement of human biomedicine.
Further Reading
The International Society of Cryobiology, founded in 1964, is the most authoritative academic organization in the field of cryobiological medicine worldwide. It aims to bring together scholars from biology, medicine, and physics to explore the effects of low temperatures on biological systems. The Society’s mission is to advance cryobiology research, deepen scientific understanding in the field, and disseminate and apply relevant achievements for the benefit of humanity. All members are required to adhere to the highest ethical and scientific standards in their professional activities.
Previous article
Latest developments
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.
The significance of life extension lies not only in technological breakthroughs but also in the shared belief of every individual who believes in "a better future." With faith as their torch, these fellow travelers join hands, pooling their strength to stride forward together. We firmly believe that as this steadfast support converges into a powerful force, it will propel the Yinfeng Life Extension Plan to gain broader attention, inject continuous momentum into the development of cryobiomedicine, and illuminate the next chapter of human civilization.
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.